Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus

Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus

Xiaowei Li,* Kunkun Cao,* Zhigang Fu,* Xiaoxia Chen, Jiaming Zhong, Li Liu, Ning Ding, Xiaoli Zhang, Zengqiang Qu, Lijun Zhu, Jian Zhai Department II of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, People’s Republic of China&...

Full description

Saved in:
Bibliographic Details
Main Authors: Li X, Cao K, Fu Z, Chen X, Zhong J, Liu L, Ding N, Zhang X, Qu Z, Zhu L, Zhai J
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
tislelizumab
portal vein tumor thrombus
lenvatinib
hepatocellular carcinoma
hepatic artery infusion chemotherapy
Online Access:https://www.dovepress.com/clinical-outcomes-of-hepatic-arterial-infusion-chemotherapy-plus-lenva-peer-reviewed-fulltext-article-JHC
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/clinical-outcomes-of-hepatic-arterial-infusion-chemotherapy-plus-lenva-peer-reviewed-fulltext-article-JHC

Similar Items